[Pathogenetic basis for using prodectin and teonicol, redergin and aescuzan in complex treatment of chronic gastritis].
The study of the microvessels in bioptates of gastric mucosa and micro haemocirculation in the conjunctiva of 254 patients with chronic gastritis revealed that exacerbation of the gastric process is going on the background of hard terminal bloodstream disorders. They have the generalized character and picture of the typical chronic relapsing trombohaemorrhagic syndrome. The use of Prodectin (250 mg), Teonicolum (150 mg), Redergin (1 tab.) and Aescuzan (25 dr.) 4 times per day during 3 weeks helps to eliminate the microcirculatory disorders and exacerbation of the chronic gastritis.
D004359:Drug Therapy, Combination; D004877:Ergoloid Mesylates / Q000008:administration & dosage / Q000627:therapeutic use*; D004928:Escin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011727:Pyridinolcarbamate / Q000008:administration & dosage / Q000627:therapeutic use*; D014971:Xanthinol Niacinate / Q000008:administration & dosage / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D004928:Escin; D004877:Ergoloid Mesylates; D011727:Pyridinolcarbamate; D014971:Xanthinol Niacinate
Patogeneticheskie osnovy primeneniia prodektina i teonikola, redergina i éskuzana pri kompleksnom lechenii khronicheskogo gastrita.